Clinical Immunization Safety Assessment (CISA) Network Publications
Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network . Recurrent Guillain-Barre Syndrome Following Vaccination. Infectious Disease Journal. 2012 Mar;54(6):800-4.
http://www.ncbi.nlm.nih.gov/pubmed/22267712
Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P; Brighton Collaboration Seizure Working Group. Generalized Convulsive Seizure as an Adverse Event Following Immunization Case Definition & Guidelines for Data Collection, Analysis, and Presentation. Vaccine. 2004 Jan 26; 22(5-6):557-62. http://www.ncbi.nlm.nih.gov/pubmed/14741144
Durbin A, Setse R, Omer S, Palmer J, Spaeder J, Baker J, Lessans F, and Halsey N. Monitoring Adverse Events Following Yellow Fever Vaccination Using an Integrated Telephone and Internet-based System. Vaccine. 2009 Oct 19; 27(44):6143-47.
http://www.ncbi.nlm.nih.gov/pubmed/19712766
Halsey NA. Anthrax Vaccine and Causality Assessment from Individual Case Reports. Pharmacoepidemiology and Drug Safety. 2002 Apr-May; 11(3):185-7. http://www.ncbi.nlm.nih.gov/pubmed/12051117
Halsey NA. The Human Papillomavirus Vaccine and Risk of Anaphylaxis. [Commentary]. CMAJ. 2008 Sep 9; 179(6):509-10. [Epub 2008 Sep 1]. Erratum in: CMAJ. 2008 Sep 23; 179(7):678. http://www.ncbi.nlm.nih.gov/pubmed/18762617
Halsey NA. The Science of Evaluation of Adverse Effects Associated with Vaccination. Seminars in Pediatric Infectious Diseases. 2002 July; 13(3):205-14.
http://www.ncbi.nlm.nih.gov/pubmed/12199617
Halsey NA, Edwards KM, Dekker CL, Klein NP, Baxter R, LaRussa P, Marchant C, Slade B, Vellozzi C; the Causality Working Group of the Clinical Immunization Safety Assessment network . Algorithm to Assess Causality after Individual Adverse Events Following Immunizations. Vaccine. 2012 Apr 13. http://www.ncbi.nlm.nih.gov/pubmed/22507656
Klein N, Aukes L, Lee J,Fireman B, Shapira S, Slade S, Baxter R, Summar S. Evaluation of Immunization Rates and Safety Among Children With Inborn Errors of Metabolism. Pediatrics. May 2011; 127 (5)1139-46 http://www.ncbi.nlm.nih.gov/pubmed/21482602?dopt=Abstract
Klein NP, Edwards KM, Sparks R and Dekker CL; on behalf of the Clinical Immunization Safety Assessment (CISA) Network. Recurrent Sterile Abscesses Following Immunization: A Possible Association with Aluminum Adjuvant. BMJ Case Reports. 2009 pii: bcr09.2008.095. http://www.ncbi.nlm.nih.gov/pubmed/21686546
Klein N, Gans H, Sung P, Yasukawa LL, Johnson J, Sarafanov A, Chumakov K, Hansen J, Black S, and Dekker CL. Preterm Infants T Cell Responses to Inactivated Poliovirus Vaccine. Journal of Infectious Diseases. 2010 Jan; 201(2): 214-22.
http://www.ncbi.nlm.nih.gov/pubmed/20017631
Klein N, Fireman B, Enright A, Ray P, Black S, and Dekker CL for the Clinical Immunization Safety Assessment (CISA) Network. Role for Genetics in the Immune Response to the Varicella Vaccine. Pediatr Inf Dis J. 2007 Apr; 26(4):300-5. http://www.ncbi.nlm.nih.gov/pubmed/17414391
Klein NP, Gidudu J, Qiang Y, Pahud B, Rowhani-Rahbar A, Baxter R, Dekker C, Edwards K, Halsey N, LaRussa P, Marchant C, Tokars J, Destefano F. Developing the Next Generation of Vaccinologists. Vaccine. 2011 Nov 21;29(50):9296-7. Epub 2011 Apr 19. http://www.ncbi.nlm.nih.gov/pubmed/21510995
Klein N, Kissner J, Aguirre A, Sparks R, Campbell S, Edwards K, Dekker C, Shui I, and Gust DA. Differential Maternal Responses to a Newly Developed Vaccine Information Pamphlet. Vaccine 2009 Dec. 11; 28:323–8. http://www.ncbi.nlm.nih.gov/pubmed/19879994
Kohl K, Magnus M, Ball R, Halsey N, Shadomy S, and Farley T. Applicability, Reliability, Sensitivity, and Specificity of Six Brighton Collaboration Standardized Case Definitions for Adverse Events Following Immunization. Vaccine. 2008 Nov 25; 26(50):6349–60.
http://www.ncbi.nlm.nih.gov/pubmed/18805456
LaRussa P, Edwards K, Dekker C, Klein N, Halsey NA, Marchant C, Baxter R, Engler R, Kissner J, Slade B.. Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment (CISA) Network. Pediatrics. 2011 May;127(5):e1147-53. http://www.ncbi.nlm.nih.gov/pubmed/21502239
Lindsey N, Schroeder B, Miller E, Braun M, Hinckley A, Marano N, Slade B, Barnett E, Brunette G, Horan K, Staples J, Kozarsky PE and Hayes E. Adverse Event Reports Following Yellow Fever Vaccination. Vaccine. 2008 Nov 11; 26(48): 6077-82.
Miller EK, Dumitrescu L, Cupp C, Dorris S, Taylor S, Sparks R, Fawkes D, Frontiero V, Rezendes AM, Marchant C, Edwards KM, Crawford DC. Atopy History and the Genomics of Wheezing after Influenza Vaccination in Children 6-59 Months of Age. Vaccine. 2011 Apr 18;29(18):3431-7
http://www.ncbi.nlm.nih.gov/pubmed/21396408
Morgan TM, Schlegel C, Edwards KM, Welch-Burke T, Zhu Y, Sparks R, Summar M; Urea Cycle Disorders Consortium. Vaccines Are Not Associated With Metabolic Events in Children With Urea Cycle Disorders Pediatrics 2011 April; peds.2010-1628v1-peds.2010-1628. http://www.ncbi.nlm.nih.gov/pubmed/21482610?dopt=Abstract
Muralles AA, Ray P, Black S, and Shinefield H. Active Telephone Surveillance to Evaluate Adverse Events Among Civilian Smallpox Vaccine Recipients. Vaccine. 2006 Jan 23; 24(4):476-84. http://www.ncbi.nlm.nih.gov/pubmed
Navar-Boggan AM, Halsey NA, Escobar GJ, Golden WC, Klein NP. Underimmunization in the Neonatal Intensive Care Unit. J Perinatol. 2011 Aug 11. doi: 10.1038/jp.2011.111. http://www.ncbi.nlm.nih.gov/pubmed/21836550
Navar-Boggan AM, Halsey NA, Golden WC, Escobar GJ, Massolo M, and Klein NP. Risk of Fever and Sepsis Evaluations Following Routine Immunizations in the Neonatal Intensive Care Unit. Journal of Perinatol. 2010 Feb 25; 30(9):632.
http://www.ncbi.nlm.nih.gov/pubmed/20182438
Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine. J Infect Dis. 2011 Feb 1;203(3):316-23.
http://www.ncbi.nlm.nih.gov/pubmed/21177308
Pahud BA, Rowhani-Rahbar A, Glaser C, Gavali S, Salibay CJ, Fireman B, Dekker CL. Lack of Association between Childhood Immunizations and Encephalitis in California, 1998-2008.
Vaccine. 2012 Jan 5;30(2):247-53. http://www.ncbi.nlm.nih.gov/pubmed/22080172
Rennels M, Black S, Woo E, Campbell S, Edwards KM. Safety of a Fifth Dose of Diphtheria and Tetanus Toxoid and Acellular Pertussis Vaccine in Children Experiencing Extensive, Local Reactions to the Fourth Dose. Pediatric Infectious Disease Journal. 2008 May; 27(5):464-465.
http://www.ncbi.nlm.nih.gov/pubmed/18398385
Rollison D, Helzlsouer K, Halsey N, Shah K, and Viscidi R. Markers of Past Infection with Simian Virus 40 (SV40) and Risk of Incident Non-Hodgkin Lymphoma in a Maryland Cohort. Cancer Epidemiol Biomarkers Prev. 2005 June; 14(6) 1448-1452.
http://www.ncbi.nlm.nih.gov/pubmed/15941954
Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, and Edwards KM. Serious Adverse Events Rarely Reported After Trivalent Inactivated Influenza Vaccine (TIV) in Children 6–23 Months of Age. Vaccine. 2009 Jul 9; 27(32):4278-83.
http://www.ncbi.nlm.nih.gov/pubmed/19450636
Rothstein E, Kohl K, Ball L, Halperin S, Halsey N, Hammer S, Heath P, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W, and Brighton Collaboration Local Reaction Working Group. Nodule at Injection Site as an Adverse Event Following Immunization Case Definition & Guidelines for Data Collection, Analysis, and Presentation. Vaccine. 2004 Jan 26; 22(5-6):575-85. http://www.ncbi.nlm.nih.gov/pubmed/14741147
Rowhani-Rahbar A, Baxter R, Rasgon B, Ray P, Black S, Klein JO, Klein NP. Epidemiologic and Clinical Features of Bell’s Palsy among Children in Northern California. Neuroepidemiology. 2012;38:252–258. Epub Jun 5, 2012. http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&ArtikelNr=338303&Ausgabe=257002&ProduktNr=224263
Rowhani-Rahbar A, Klein NP, Lewis N, Fireman B, Ray P, Rasgon B, Black S, Klein JO, Baxter R. Immunization and Bell’s palsy in children: A case-centered Analysis. Am J Epidemiol. 2012;175:878-85.
Sekaran N, Edwards, K. Extensive Swelling Reaction Associated with Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):374-5. http://www.ncbi.nlm.nih.gov/pubmed/16567996
Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus Shedding in Premature Infants Following First Immunization. Vaccine. 2011 Oct 19;29(45):8141-6. http://www.ncbi.nlm.nih.gov/pubmed/21856359
Top K, Yen C, Esquilin J, Esona M, Gentsch J, Bhatia M, LaRussa P. Detection of Mutations in Antigenic Regions of Rotavirus Viral Proteins 4 and 7 in a Child with Chronic Shedding of Rotavirus Vaccine-type Strain. The Pediatric Infectious Disease Journal. July; 30(7):630, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21673551
Vannice KS, Salmon DA, Shui I, Omer SB, Kissner J, Edwards KM, Sparks R, Dekker CL, Klein NP, Gust DA. Attitudes and Beliefs of Parents Concerned about Vaccines: Impact of Timing of Immunization Information. Pediatrics. 2011 May;127 Suppl 1:S120-6
http://www.ncbi.nlm.nih.gov/pubmed/21502250?dopt=Abstract.
Vellozzi C, Mitchell T, Miller E, Casey CG, Eidex RB, Hayes EB, The Yellow Fever Vaccine Working Group (Halsey NA contributor). Yellow Fever Vaccine-Associated Viscerotropic Disease (YEL-AVD) and Corticosteroid Therapy: Eleven United States Cases, 1996-2004. Am J Trop Med Hyg. 2006 August; 75(2):333-6. http://www.ncbi.nlm.nih.gov/pubmed/16896144
Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, LaRussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM. Overview of the Clinical Consult Case Review of Adverse Events Following Immunization: Clinical Immunization Safety Assessment (CISA) Network 2004-2009. Vaccine. 2011 Sep 16;29(40):6920.-
http://www.ncbi.nlm.nih.gov/pubmed/21801776
Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM. Causality Assessment of Serious Neurologic Adverse Events Following 2009 H1N1 Vaccination. Vaccine. 2011 Oct 26;29(46):8302-8.
http://www.ncbi.nlm.nih.gov/pubmed/21893148
Wood R, Berger M, Dreskin S, Setse R, Engler R, Dekker L, Halsey N & The Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. Algorithm for Treatment of Patients with Hypersensitivity Reactions After Vaccines. Pediatrics. 2008 September; 122(3): e771-7. http://www.ncbi.nlm.nih.gov/pubmed/18762513
Wood RA, Setse R, Halsey N, and the Hypersensitivity Working Group of the Clinical Immunization Safety Assessment (CISA) Network. Irritant Skin Test Reactions to Common Vaccines. Journal of Allergy and Clinical Immunology. 2007 Aug; 120(2):478-81.
http://www.ncbi.nlm.nih.gov/pubmed/17544094
Yen C, Jakob K, Hittier X, Gentsch J, LaRussa P, for the Clinical Immunization Safety Assessment (CISA) Network. Detection of Fecal Shedding of Rotavirus Vaccine in Infants Following Their First Dose of Pentavalent Rotavirus Vaccine. Vaccine. May 31;29(24):4151-5, 2011.
http://www.ncbi.nlm.nih.gov/pubmed/21477676
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov